Advertisement
Advertisement
CRVS
Corvus Pharmaceuticals, Inc.
13.92
USDSponsored
+0.06
+0.43%
Aug 07, 15:59 UTC -4
Closed
After-Market
13.52
-0.40
-2.91%
Corvus Pharmaceuticals, Inc. Financial Snapshot
| Market Cap | 1.14B |
| Beta | 0.87 |
| Earnings Per Share (EPS) | -0.61 |
| Price-to-Book (P/B) Ratio | 4.86 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -43.46% |
| Current Ratio | 16.16% |
| Free Cash Flow | -26.45M |
Trending Stocks
Advertisement